MedTrace Logo

The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease

NCT01277237 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-01-23

No results posted yet for this study

Summary

There is preliminary evidence that Omega 3, a compound naturally found in fish oil, reduces the amount of fat stored in the liver and improves liver function. The purpose of this study is to see whether this observation is correct.

Conditions

  • Non Alcoholic Fatty Liver Disease

Interventions

DRUG

Omacor

Active comparator: omacor 4g/day

DRUG

lactose tablet

placebo: lactose tablet 4g/day

Sponsors & Collaborators

  • NHS Lothian

    collaborator OTHER_GOV

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Peter C Hayes, MD PhD · Royal Infirmary of Edinburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01277237 on ClinicalTrials.gov